185 related articles for article (PubMed ID: 25804087)
1. The Effect of Duration of Penile Traction Therapy in Patients Undergoing Intralesional Injection Therapy for Peyronie's Disease.
Yafi FA; Pinsky MR; Stewart C; Sangkum P; Ates E; Trost LW; Sikka SC; Hellstrom WJ
J Urol; 2015 Sep; 194(3):754-8. PubMed ID: 25804087
[TBL] [Abstract][Full Text] [Related]
2. Intralesional Injection of Interferon-α2b Improves Penile Curvature in Men with Peyronie's Disease Independent of Plaque Location.
Stewart CA; Yafi FA; Knoedler M; Mandava SH; McCaslin IR; Sangkum P; Sikka S; Trost L; Hellstrom WJ
J Urol; 2015 Dec; 194(6):1704-7. PubMed ID: 26144333
[TBL] [Abstract][Full Text] [Related]
3. Combination of penile traction, intralesional verapamil, and oral therapies for Peyronie's disease.
Abern MR; Larsen S; Levine LA
J Sex Med; 2012 Jan; 9(1):288-95. PubMed ID: 22024053
[TBL] [Abstract][Full Text] [Related]
4. The impact of intralesional interferon alpha-2b injection therapy on penile hemodynamics in men with Peyronie's disease.
Kendirci M; Usta MF; Matern RV; Nowfar S; Sikka SC; Hellstrom WJ
J Sex Med; 2005 Sep; 2(5):709-15. PubMed ID: 16422829
[TBL] [Abstract][Full Text] [Related]
5. Comparative Analysis of Tunical Plication vs. Intralesional Injection Therapy for Ventral Peyronie's Disease.
Yafi FA; Hatzichristodoulou G; Knoedler CJ; Trost LW; Sikka SC; Hellstrom WJ
J Sex Med; 2015 Dec; 12(12):2492-8. PubMed ID: 26646187
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of Combined Collagenase Clostridium histolyticum and RestoreX Penile Traction Therapy in Men with Peyronie's Disease.
Alom M; Sharma KL; Toussi A; Kohler T; Trost L
J Sex Med; 2019 Jun; 16(6):891-900. PubMed ID: 30956106
[TBL] [Abstract][Full Text] [Related]
7. Outcomes of a Novel Penile Traction Device in Men with Peyronie's Disease: A Randomized, Single-Blind, Controlled Trial.
Ziegelmann M; Savage J; Toussi A; Alom M; Yang D; Kohler T; Trost L
J Urol; 2019 Sep; 202(3):599-610. PubMed ID: 30916626
[TBL] [Abstract][Full Text] [Related]
8. Single-blind, multicenter, placebo controlled, parallel study to assess the safety and efficacy of intralesional interferon alpha-2B for minimally invasive treatment for Peyronie's disease.
Hellstrom WJ; Kendirci M; Matern R; Cockerham Y; Myers L; Sikka SC; Venable D; Honig S; McCullough A; Hakim LS; Nehra A; Templeton LE; Pryor JL
J Urol; 2006 Jul; 176(1):394-8. PubMed ID: 16753449
[TBL] [Abstract][Full Text] [Related]
9. Intralesional interferon-alpha-2b for the treatment of Peyronie's disease.
Lacy GL; Adams DM; Hellstrom WJ
Int J Impot Res; 2002 Oct; 14(5):336-9. PubMed ID: 12454683
[TBL] [Abstract][Full Text] [Related]
10. Clinical Efficacy of Injection and Mechanical Therapy for Peyronie's Disease: A Systematic Review of the Literature.
Russo GI; Milenkovic U; Hellstrom W; Levine LA; Ralph D; Albersen M
Eur Urol; 2018 Dec; 74(6):767-781. PubMed ID: 30237020
[TBL] [Abstract][Full Text] [Related]
11. Outcomes of intralesional interferon-α2B for the treatment of Peyronie disease.
Trost LW; Ates E; Powers M; Sikka S; Hellstrom WJ
J Urol; 2013 Dec; 190(6):2194-9. PubMed ID: 23688848
[TBL] [Abstract][Full Text] [Related]
12. Effect of intralesional interferon-alpha 2b combined with oral vitamin E for treatment of early stage Peyronie's disease: a randomized and prospective study.
Inal T; Tokatli Z; Akand M; Ozdiler E; Yaman O
Urology; 2006 May; 67(5):1038-42. PubMed ID: 16581113
[TBL] [Abstract][Full Text] [Related]
13. Combined intralesional interferon alpha 2B and oral vitamin E in the treatment of Peyronie's disease.
Novak TE; Bryan W; Templeton L; Sikka S; Hellstrom WJ
J La State Med Soc; 2001 Jul; 153(7):358-63. PubMed ID: 11519219
[TBL] [Abstract][Full Text] [Related]
14. Ten-year experience with multimodal treatment for acute phase Peyronie's disease: A real life clinical report.
Gallo L; Sarnacchiaro P
Actas Urol Esp (Engl Ed); 2019 May; 43(4):182-189. PubMed ID: 30704797
[TBL] [Abstract][Full Text] [Related]
15. Penile traction therapy with the new device 'Penimaster PRO' is effective and safe in the stable phase of Peyronie's disease: a controlled multicentre study.
Moncada I; Krishnappa P; Romero J; Torremade J; Fraile A; Martinez-Salamanca JI; Porst H; Levine L
BJU Int; 2019 Apr; 123(4):694-702. PubMed ID: 30365247
[TBL] [Abstract][Full Text] [Related]
16. Intralesional interferon in the treatment of Peyronie's disease: a pilot study.
Judge IS; Wisniewski ZS
Br J Urol; 1997 Jan; 79(1):40-2. PubMed ID: 9043494
[TBL] [Abstract][Full Text] [Related]
17. Treatment of Peyronie's Disease With Collagenase Clostridium histolyticum and Vacuum Therapy: A Randomized, Open-Label Pilot Study.
Ralph DJ; Abdel Raheem A; Liu G
J Sex Med; 2017 Nov; 14(11):1430-1437. PubMed ID: 28974406
[TBL] [Abstract][Full Text] [Related]
18. A pilot study demonstrating clinical benefit from intralesional interferon alpha 2B in the treatment of Peyronie's disease.
Ahuja S; Bivalacqua TJ; Case J; Vincent M; Sikka SC; Hellstrom WJ
J Androl; 1999; 20(4):444-8. PubMed ID: 10452584
[TBL] [Abstract][Full Text] [Related]
19. Clinical Experience With Penile Traction Therapy Among Men Undergoing Collagenase Clostridium histolyticum for Peyronie Disease.
Ziegelmann MJ; Viers BR; Montgomery BD; Avant RA; Savage JB; Trost LW
Urology; 2017 Jun; 104():102-109. PubMed ID: 28347795
[TBL] [Abstract][Full Text] [Related]
20. A retrospective comparative study of traction therapy vs. no traction following tunica albuginea plication or partial excision and grafting for Peyronie's disease: measured lengths and patient perceptions.
Rybak J; Papagiannopoulos D; Levine L
J Sex Med; 2012 Sep; 9(9):2396-403. PubMed ID: 22900621
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
